Induction of astrocytic cyclooxygenase-2 in epileptic patients with hippocampal sclerosis
dc.contributor.author | Desjardins, Paul | |
dc.contributor.author | Sauvageau, Anny | |
dc.contributor.author | Bouthillier, Alain | |
dc.contributor.author | Navarro, Darren | |
dc.contributor.author | Hazell, Alan S. | |
dc.contributor.author | Rose, Christopher | |
dc.contributor.author | Butterworth, Roger | |
dc.date.accessioned | 2013-04-25T19:01:42Z | |
dc.date.available | 2013-04-25T19:01:42Z | |
dc.date.issued | 2003 | |
dc.identifier.uri | http://hdl.handle.net/1866/9586 | |
dc.subject | Astrocytes | en |
dc.subject | Cyclooxygenase 2 | en |
dc.subject | Épilepsie temporale | en |
dc.subject | Prostaglandines | en |
dc.subject | Prostaglandins | en |
dc.subject | Temporal lobe epilepsy | en |
dc.title | Induction of astrocytic cyclooxygenase-2 in epileptic patients with hippocampal sclerosis | |
dc.type | Article | en |
dc.contributor.affiliation | Université de Montréal. Faculté de médecine. Centre de recherche du CHUM | fr |
dc.contributor.affiliation | Université de Montréal. Faculté de médecine | fr |
dc.identifier.doi | 10.1016/S0197-0186(02)00101-8 | |
dcterms.abstract | Induction of cyclooxygenase-2 (COX-2) has been described in a wide range of neurological diseases including animal models of epilepsy. The present study was undertaken to assess COX-2 expression in hippocampal biopsies from patients with therapy-refractive temporal lobe epilepsy (TLE). For this purpose, hippocampal CA1 subfield was dissected from epileptic patients with (n=5) or without (n=2) hippocampal sclerosis (HS). COX-2 expression was investigated using immunohistochemistry and semi-quantitative RT-PCR. COX-2 immunoreactivity in TLE patient material in the absence of HS was restricted to a few neurons of the hippocampus. In the presence of HS, on the other hand, a significant induction of astrocytic COX-2 immunoreactivity associated with a concomitant increase in the steady-state level of COX-2 mRNA was observed in the CA1 subfield. These findings suggest that induction of astrocytic COX-2 is implicated in the pathogenesis of HS in TLE and is consistent with the previous findings of increased concentrations of prostaglandins in the cerebrospinal fluid of these patients. | en |
dcterms.language | eng | en |
UdeM.VersionRioxx | Version acceptée / Accepted Manuscript | |
oaire.citationTitle | Neurochemistry international | |
oaire.citationVolume | 42 | |
oaire.citationIssue | 4 | |
oaire.citationStartPage | 299 | |
oaire.citationEndPage | 303 |
Files in this item
This item appears in the following Collection(s)
This document disseminated on Papyrus is the exclusive property of the copyright holders and is protected by the Copyright Act (R.S.C. 1985, c. C-42). It may be used for fair dealing and non-commercial purposes, for private study or research, criticism and review as provided by law. For any other use, written authorization from the copyright holders is required.